Spatial iTME analysis of KRAS mutant NSCLC and immunotherapy outcome.
Zhao D, Li H, Mambetsariev I, Mirzapoiazova T, Chen C, Fricke J, Wheeler D, Arvanitis L, Pillai R, Afkhami M, Chen BT, Sattler M, Erhunmwunsee L, Massarelli E, Kulkarni P, Amini A, Armstrong B, Salgia R.
Zhao D, et al. Among authors: armstrong b.
NPJ Precis Oncol. 2024 Jun 19;8(1):135. doi: 10.1038/s41698-024-00626-6.
NPJ Precis Oncol. 2024.
PMID: 38898200
Free PMC article.